Correction: Prognostic impact of donor mitochondrial genomic variants in myelodysplastic neoplasms after stem-cell transplantation

Abstract

Correction: Journal of Hematology & Oncology (2024) 17:104 https://doi.org/10.1186/s13045-024-01622-w

The authors wish to note the following amendments to the affiliations and the funding in the original article.

The affiliations should instead be as follows:

• Wael Saber:

CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI

• Paul Auer:

Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI

CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI

Cancer Center Biostatistics Shared Resource, Medical College of Wisconsin, Milwaukee, WI

• Zhongyuan Chen:

Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI

CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI

The Funding should instead read as follows:

Jing Dong is supported by the NHLBI (K01 HL164972) and the Medical College of Wisconsin Cancer Center. N00014-17-1-2850 from the Office of Naval Research. CIBMTR is supported primarily by the Public Health Service U24CA076518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases (NIAID); 75R60222C00011 from the Health Resources and Services Administration (HRSA); and N00014-23-1-2057 and N00014-24-1-2057 from the Office of Naval Research. Support is also provided by the Medical College of Wisconsin, NMDP, Gateway for Cancer Research, Pediatric Transplantation and Cellular Therapy Consortium and from the following commercial entities: AbbVie; Actinium Pharmaceuticals, Inc.; Adaptive Biotechnologies Corporation; ADC Therapeutics; Adienne SA; Alexion; AlloVir, Inc.; Amgen, Inc.; Astellas Pharma US; AstraZeneca; Atara Biotherapeutics; BeiGene; BioLineRX; Blue Spark Technologies; bluebird bio, inc.; Blueprint Medicines; Bristol Myers Squibb Co.; CareDx Inc.; CSL Behring; CytoSen Therapeutics, Inc.; DKMS; Elevance Health; Eurofins Viracor, DBA Eurofins Transplant Diagnostics; Gamida-Cell, Ltd.; Gift of Life Biologics; Gift of Life Marrow Registry; GlaxoSmithKline; HistoGenetics; Incyte Corporation; Iovance; Janssen Research & Development, LLC; Janssen/Johnson & Johnson; Jasper Therapeutics; Jazz Pharmaceuticals, Inc.; Karius; Kashi Clinical Laboratories; Kiadis Pharma; Kite, a Gilead Company; Kyowa Kirin; Labcorp; Legend Biotech; Mallinckrodt Pharmaceuticals; Med Learning Group; Medac GmbH; Merck & Co.; Mesoblast; Millennium, the Takeda Oncology Co.; Miller Pharmacal Group, Inc.; Miltenyi Biotec, Inc.; MorphoSys; MSA-EDITLife; Neovii Pharmaceuticals AG; Novartis Pharmaceuticals Corporation; Omeros Corporation; OptumHealth; Orca Biosystems, Inc.; OriGen BioMedical; Ossium Health, Inc.; Pfizer, Inc.; Pharmacyclics, LLC, An AbbVie Company; PPD Development, LP; REGiMMUNE; Registry Partners; Rigel Pharmaceuticals; Sanofi; Sarah Cannon; Seagen Inc.; Sobi, Inc.; Stemcell Technologies; Stemline Technologies; STEMSOFT; Takeda Pharmaceuticals; Talaris Therapeutics; Vertex Pharmaceuticals; Vor Biopharma Inc.; Xenikos BV.

Authors and Affiliations

1. Division of Hematology Oncology, Department of Medicine, Medical College of Wisconsin, 8701 Watertown Plank Road, HRC 5860, Milwaukee, WI, 53226, USA

   Jing Dong & Shahram Arsang-Jang

2. Medical College of Wisconsin Cancer Center, Milwaukee, WI, USA

   Jing Dong

3. Linda T. and John A. Mellowes Center for Genomic Sciences and Precision Medicine, Medical College of Wisconsin, Milwaukee, WI, USA

   Jing Dong & Raul Urrutia

4. CIBMTR® (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN, USA

   Tao Zhang, Yung-Tsi Bolon & Stephen Spellman

5. Division of Biostatistics, Data Science Institute, Medical College of Wisconsin, Milwaukee, WI, USA

   Zhongyuan Chen & Paul Auer

6. CIBMTR® (Center for International Blood and Marrow Transplant Research), Medical College of Wisconsin, Milwaukee, WI, USA

   Zhongyuan Chen, Paul Auer & Wael Saber

7. Cancer Center Biostatistics Shared Resource, Medical College of Wisconsin, Milwaukee, WI, USA

   Paul Auer

Authors

1. Jing DongView author publications

   You can also search for this author in PubMed Google Scholar

2. Shahram Arsang-JangView author publications

   You can also search for this author in PubMed Google Scholar

3. Tao ZhangView author publications

   You can also search for this author in PubMed Google Scholar

4. Zhongyuan ChenView author publications

   You can also search for this author in PubMed Google Scholar

5. Yung-Tsi BolonView author publications

   You can also search for this author in PubMed Google Scholar

6. Stephen SpellmanView author publications

   You can also search for this author in PubMed Google Scholar

7. Raul UrrutiaView author publications

   You can also search for this author in PubMed Google Scholar

8. Paul AuerView author publications

   You can also search for this author in PubMed Google Scholar

9. Wael SaberView author publications

   You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jing Dong.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.

Reprints and permissions

Cite this article

Dong, J., Arsang-Jang, S., Zhang, T. et al. Correction: Prognostic impact of donor mitochondrial genomic variants in myelodysplastic neoplasms after stem-cell transplantation. J Hematol Oncol 18, 13 (2025). https://doi.org/10.1186/s13045-025-01662-w

Download citation

• Published: 03 February 2025

• DOI: https://doi.org/10.1186/s13045-025-01662-w

Share this article

Anyone you share the following link with will be able to read this content:

Get shareable link

Sorry, a shareable link is not currently available for this article.

Copy to clipboard

Provided by the Springer Nature SharedIt content-sharing initiative